Dulik Elena
Known title: Chief Accounting Officer, SVPCIK: 0001574998
Associated companies
Transaction History
| CNS | ▲ Buy | Grant | 39 | $0 | 8/20/2026 | View on chart |
| CNS | ▼ Sell | Open Market | 1,100 | $91K | 7/20/2026 | View on chart |
| CNS | ▲ Buy | Grant | 46 | $0 | 5/21/2026 | View on chart |
| CNS | ▲ Buy | Grant | 52 | $0 | 3/19/2026 | View on chart |
| CNS | ▼ Sell | Tax Withholding | 757 | $49K | 1/30/2026 | View on chart |
| CNS | ▲ Buy | Grant | 2,394 | $0 | 1/30/2026 | View on chart |
| CNS | ▲ Buy | Grant | 46 | $0 | 11/20/2025 | View on chart |
| CNS | ▲ Buy | Grant | 38 | $0 | 8/21/2025 | View on chart |
| CNS | ▲ Buy | Grant | 35 | $0 | 5/22/2025 | View on chart |
| CNS | ▲ Buy | Grant | 35 | $0 | 3/13/2025 | View on chart |
| CNS | ▼ Sell | Tax Withholding | 815 | $72K | 1/31/2025 | View on chart |
| CNS | ▲ Buy | Grant | 1,579 | $0 | 1/31/2025 | View on chart |
| CNS | ▲ Buy | Grant | 26 | $0 | 12/2/2024 | View on chart |
| CNS | ▲ Buy | Grant | 34 | $0 | 8/22/2024 | View on chart |
| CNS | ▼ Sell | Open Market | 1,100 | $95K | 7/26/2024 | View on chart |
| CNS | ▲ Buy | Grant | 40 | $0 | 5/23/2024 | View on chart |
| CNS | ▲ Buy | Grant | 40 | $0 | 3/14/2024 | View on chart |
| CNS | ▼ Sell | Tax Withholding | 813 | $59K | 1/31/2024 | View on chart |
| CNS | ▲ Buy | Grant | 1,900 | $0 | 1/31/2024 | View on chart |
| CNS | ▼ Sell | Open Market | 725 | $45K | 12/7/2023 | View on chart |
| CNS | ▲ Buy | Grant | 50 | $0 | 11/28/2023 | View on chart |
| CNS | ▲ Buy | Grant | 45 | $0 | 8/24/2023 | View on chart |
| CNS | ▼ Sell | Open Market | 1,950 | $129K | 7/24/2023 | View on chart |
| CNS | ▲ Buy | Grant | 53 | $0 | 5/25/2023 | View on chart |
| CNS | ▲ Buy | Grant | 45 | $0 | 3/16/2023 | View on chart |
| CNS | ▼ Sell | Tax Withholding | 1,068 | $77K | 1/31/2023 | View on chart |
| CNS | ▲ Buy | Grant | 2,152 | $0 | 1/31/2023 | View on chart |
| CNS | ▲ Buy | Grant | 44 | $0 | 11/29/2022 | View on chart |
| CNS | ▲ Buy | Grant | 38 | $0 | 8/25/2022 | View on chart |
| CNS | ▼ Sell | Open Market | 1,200 | $89K | 8/1/2022 | View on chart |
| CNS | ▲ Buy | Grant | 38 | $0 | 5/26/2022 | View on chart |
| CNS | ▲ Buy | Grant | 35 | $0 | 3/17/2022 | View on chart |
| CNS | ▼ Sell | Tax Withholding | 1,264 | $103K | 1/31/2022 | View on chart |
| CNS | ▲ Buy | Grant | 2,029 | $0 | 1/31/2022 | View on chart |
| CNS | ▲ Buy | Grant | 115 | $0 | 11/30/2021 | View on chart |
| CNS | ▲ Buy | Grant | 31 | $0 | 8/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Cohen & Steers (CNS) eyes Q3 2026 results amid REIT sector resilience
A recent article highlights that REITs are holding up despite rising interest rates, driven by solid fundamentals. Cohen & Steers, Inc. is scheduled to release its third‑quarter 2026 earnings on October 15, providing more detail on its performance. The broader REIT strength may be relevant for CNS as it operates within that market.
Cohen & Steers (CNS) eyes Q3 2026 results amid REIT sector resilience. A recent article highlights that REITs are holding up despite rising interest rates, driven by solid fundamentals. Cohen & Steers, Inc. is scheduled to release its third‑quarter 2026 earnings on October 15, providing more detail on its performance. The broader REIT strength may be relevant for CNS as it operates within that market.